Galicia vaccine over 70 flu with this dose

Changes in Covid-19 vaccination and this year’s flu

The clinical trial GalfluGalicia’s pioneering project on the high -load vaccine against flu, demonstrated the effectiveness of this dose to the Reduce hospitalizations by 31.8% compared to the standard vaccine.

The Ministry of Sanidade, Antonio Gómez Caamañothe results of the study presented at a press conference, accompanied by the general director of Public Health, Carmen Duránof the researcher Federico Martinón, Responsible for the Group of Genetics, Vaccines and Infectious Diseases of the Institute of Health Research of Santiago de Compostela.

The head of Health also stressed the reduction of the Risk of flu hospitalization or pneumonia of 23.7% with the reinforced flu vaccine and 8.4% of hospitalizations for cardiorespiratory events.

Gómez Caamaño reiterated the decision of the Xunta of, once its effective 70 to 79 years.

In previous campaigns it was already administered At older than 80 yearsas well as residents in socio -health centers and immunosuppressed people.

The Department of Health thanked the involvement of Galician citizenship with almost 135,000 participants In the last two vaccination campaigns.

Gómez Caamaño explained that, with the sending of SMS to invite people from 65 to 79 years As well as with the invitations in the vaccination centers themselves, it was possible to close the necessary recruitment in just one month. I also expressly thank the 200 nurses of the Galician Servizo de Saúde who collaborated in the project.

The results of Galflu, one of the largest clinical trials carried out in Spain In the field of vaccinesthey have just been published by the relevance of their findings in the magazine New England Journal of Medicineone of the most prominent internationally.

Gómez Caamaño insisted on the success of the Xunta in betting on the Applied Clinical Research to optimize public health policies. Thus, the study shows the benefits of a rigorous planning and evaluation of the Galician vaccination system.

Shared Risk Agreement

For the next campaign in front of the flu, Galicia will be the first region worldwide in boost a vaccine acquisition system take into account the results and real effectiveness in patients.

The Xunta will allocate more than 7.2 million euros At the first purchase of vaccines against high -load flu in the modality of shared risk agreement, which is based on obtaining health results and that allows adjusting the price of vaccines based on their ability to reduce hospitalizations.